Literature DB >> 8292673

Relationships between increased haptoglobin plasma levels and activation of cell-mediated immunity in depression.

M Maes1, S Scharpé, H Y Meltzer, P Cosyns.   

Abstract

Recently, it was found that major depression is accompanied by an acute phase (AP) response with increased haptoglobin (Hp) plasma levels and various indices of systemic immune stimulation. The present study has been carried out in order to determine the relationships between hyperhaptoglobinemia and indices of systemic immune activation in severe depression. Toward this end, the authors investigated the relationships between Hp levels and number of leukocytes, monocytes, neutrophils, lymphocytes, and activated T lymphocytes (CD25+, HLA-DR+), in depression. Hp plasma levels were significantly higher in major depressed subjects as compared to healthy controls and minor depressives. There was a significant positive correlation between Hp levels and severity of illness. Hp plasma levels showed significant and positive relationships with the absolute number of leukocytes, neutrophils, monocytes, CD25+ and HLA-DR+ T cells. Up to 35% of the variance in Hp levels could be explained by the regression on the number of neutrophils and HLA-DR+ T cells. The results show that hyperhaptoglobinemia in major depression is significantly related to activation of cell-mediated immunity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8292673     DOI: 10.1016/0006-3223(93)90042-c

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  6 in total

1.  Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression.

Authors:  M J Robertson; R S Schacterle; G A Mackin; S N Wilson; K L Bloomingdale; J Ritz; A L Komaroff
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

2.  Development of a Novel Retina-Based Diagnostic Score for Early Detection of Major Depressive Disorder: An Interdisciplinary View.

Authors:  Xiao Liu; Shunkai Lai; Shisi Ma; Hong Yang; Lian Liu; Guocheng Yu; Shuming Zhong; Yanbin Jia; Jingxiang Zhong
Journal:  Front Psychiatry       Date:  2022-05-19       Impact factor: 5.435

Review 3.  The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression.

Authors:  Michael Maes; Raz Yirmyia; Jens Noraberg; Stefan Brene; Joe Hibbeln; Giulia Perini; Marta Kubera; Petr Bob; Bernard Lerer; Mario Maj
Journal:  Metab Brain Dis       Date:  2008-12-16       Impact factor: 3.584

Review 4.  The role of immune abnormality in depression and cardiovascular disease.

Authors:  Ru-Hui Liu; Jiang-Qi Pan; Xian-E Tang; Bing Li; Shang-Feng Liu; Wen-Lin Ma
Journal:  J Geriatr Cardiol       Date:  2017-11       Impact factor: 3.327

5.  Lack of association of acute phase response proteins with hormone levels and antidepressant medication in perimenopausal depression.

Authors:  Sokratis E Karaoulanis; Katerina A Rizouli; Andreas A Rizoulis; Nikiforos V Angelopoulos
Journal:  BMC Psychiatry       Date:  2014-06-04       Impact factor: 3.630

6.  Association between Serum Ferritin Concentrations and Depressive Symptoms among Chinese Adults: A Population Study from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIHealth) Cohort Study.

Authors:  Qian Su; Yeqing Gu; Bin Yu; Fei Yu; Haiyan He; Qing Zhang; Ge Meng; Hongmei Wu; Huanmin Du; Li Liu; Hongbin Shi; Yang Xia; Xiaoyan Guo; Xing Liu; Chunlei Li; Xue Bao; Fangfang Liu; Liyun Fang; Huijun Yang; Shaomei Sun; Xing Wang; Ming Zhou; Qiyu Jia; Honglin Zhao; Kun Song; Kaijun Niu
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.